Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22559,178,1.02 [0.87-1.21],0.7994472112761998
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23590,193,1.17 [1.00-1.37],0.0470117905492102
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23341,1403,1.04 [0.98-1.10],0.2242445219081844
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,23601,381,1.09 [0.97-1.21],0.1541295993335393
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22914,3459,1.03 [1.00-1.07],0.0723841302768955
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22873,3464,1.02 [0.99-1.06],0.2106994090672168
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23389,1045,1.03 [0.96-1.10],0.3909815314283962
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23525,82,0.95 [0.74-1.22],0.6757303716547444
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21401,1116,1.05 [0.98-1.12],0.1576708016738358
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20651,1234,1.05 [0.98-1.11],0.1690631810359881
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20368,252,1.14 [0.99-1.31],0.0661920166640789
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16599,2251,1.03 [0.98-1.08],0.2784282353608363
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20297,404,1.15 [1.03-1.28],0.0117650667064893
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23594,1250,1.05 [0.98-1.11],0.1456712494744192
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23691,471,1.06 [0.96-1.17],0.2740613303902073
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22827,889,1.04 [0.96-1.12],0.3344772449731025
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23614,1233,1.04 [0.98-1.11],0.1796222936651789
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22539,195,1.16 [0.99-1.35],0.0671748237710279
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23730,51,1.31 [0.98-1.77],0.0709691043271755
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23456,1075,1.04 [0.97-1.11],0.2746365863094783
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23515,72,1.42 [1.11-1.81],0.0049215197279228
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23668,121,1.25 [1.03-1.52],0.0216016375121763
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23647,100,1.35 [1.10-1.67],0.0048596306590202
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22428,490,1.14 [1.03-1.26],0.0089623493772009
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22225,287,0.99 [0.87-1.12],0.8404283345017816
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22433,89,1.08 [0.86-1.36],0.5127274112345621
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23711,69,0.87 [0.67-1.14],0.3235644863039165
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23676,142,1.08 [0.90-1.30],0.4145622343058334
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral warts,23586,52,1.21 [0.90-1.63],0.2053373682801747
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23584,50,0.98 [0.71-1.34],0.8994901397854276
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23411,340,0.93 [0.82-1.05],0.2176213971827186
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23658,44,1.05 [0.76-1.46],0.7669796599486747
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23625,53,0.96 [0.71-1.29],0.7698898383266538
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23680,129,0.92 [0.76-1.13],0.4327690058573707
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23357,1636,1.02 [0.97-1.08],0.3872986689208481
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of meninges,23730,32,1.12 [0.76-1.64],0.5678627412924226
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23667,67,1.01 [0.77-1.32],0.9685859060494152
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23714,78,1.03 [0.80-1.32],0.8422638370977893
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23705,442,1.02 [0.91-1.13],0.7732112798837624
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Caecum,23700,338,1.06 [0.94-1.19],0.3722840861804783
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23601,83,0.93 [0.73-1.19],0.5765259399399952
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,23697,279,1.05 [0.92-1.20],0.4295699022588225
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23657,421,0.93 [0.84-1.04],0.1967902683828776
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23608,727,1.01 [0.93-1.09],0.8530409842857583
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23686,558,1.10 [1.00-1.20],0.0509319063304591
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18432,70,1.20 [0.93-1.55],0.1705064175834152
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18430,68,0.86 [0.65-1.13],0.2812772009051858
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23699,100,1.00 [0.80-1.24],0.9897579156631888
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",23699,97,1.01 [0.81-1.27],0.9135510719338992
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lung cancer and mesothelioma,15787,343,1.08 [0.96-1.21],0.214266597663041
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Lymphoid leukaemia,18426,64,1.18 [0.90-1.55],0.231815661979952
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18563,201,1.06 [0.90-1.23],0.4842818814528423
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18653,291,1.00 [0.88-1.14],0.9888052905833848
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18452,90,0.84 [0.66-1.07],0.1612792634218972
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18504,142,1.04 [0.86-1.25],0.6848134949205532
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18502,140,0.97 [0.81-1.18],0.7871160567143072
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18445,83,1.01 [0.79-1.29],0.9284383121634022
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19750,1388,0.98 [0.93-1.04],0.5734703854942916
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18507,145,0.96 [0.80-1.15],0.6576291285082239
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18468,106,1.23 [1.00-1.51],0.0511051497392595
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18492,130,1.03 [0.85-1.26],0.730388557101084
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,23603,170,0.93 [0.79-1.11],0.425331289982193
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of trunk,23698,95,1.10 [0.88-1.37],0.3918154135291087
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanoma in situ,18395,74,1.17 [0.91-1.51],0.222013292578198
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18460,98,0.91 [0.72-1.14],0.4037659318410426
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18528,166,0.92 [0.78-1.10],0.3765242517188366
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18579,217,1.03 [0.89-1.20],0.6990623774442288
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18463,101,0.89 [0.71-1.12],0.31991131704544
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,23597,137,1.03 [0.86-1.24],0.7386686790846568
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19558,1196,0.99 [0.93-1.06],0.7921194775544766
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19634,1272,1.00 [0.94-1.07],0.8862063642513788
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23455,310,1.05 [0.92-1.18],0.488341408312368
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22002,118,1.07 [0.87-1.31],0.5384910400584019
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23217,72,1.03 [0.79-1.33],0.8274020628201062
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23178,2784,1.02 [0.98-1.06],0.3391341918075036
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22448,61,1.38 [1.05-1.81],0.0195687891623887
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23310,53,0.72 [0.52-0.98],0.0390424219936471
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23358,1474,1.05 [0.99-1.11],0.085458370876483
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23356,1472,1.05 [0.99-1.11],0.0942663034256254
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21988,104,0.93 [0.74-1.15],0.493475982252719
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23491,1104,1.10 [1.03-1.18],0.0041312668294173
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23360,103,1.03 [0.83-1.28],0.7967556860997727
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23222,77,0.96 [0.74-1.23],0.7385182966832646
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23206,61,1.05 [0.79-1.39],0.7210524184894638
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23569,312,0.70 [0.62-0.80],1.901567943985515e-07
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23634,48,0.91 [0.66-1.25],0.5485417841854636
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23509,252,0.66 [0.57-0.76],2.5075463230033224e-08
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22464,77,0.87 [0.67-1.14],0.312858587992747
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17471,378,1.06 [0.95-1.19],0.3154180473556702
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21702,164,1.09 [0.92-1.29],0.3418776096083933
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21729,191,1.09 [0.93-1.27],0.3045692953045721
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17149,56,0.97 [0.72-1.30],0.8208422629002217
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22355,65,0.80 [0.60-1.06],0.125370060981042
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21589,225,0.96 [0.83-1.12],0.6080412686855953
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23225,612,1.00 [0.91-1.09],0.9597299203276356
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22855,242,0.91 [0.79-1.06],0.2159487989467165
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22779,166,1.10 [0.93-1.31],0.2681938532366958
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23429,1139,1.11 [1.04-1.19],0.0012608865089071
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20306,1097,1.10 [1.03-1.18],0.0040298667699631
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17166,73,0.75 [0.57-0.98],0.0352690574152208
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22853,39,0.99 [0.69-1.41],0.9349496205683672
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17365,272,1.19 [1.04-1.35],0.0113450244833236
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17169,76,1.12 [0.87-1.44],0.3711389878281108
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20969,3876,1.07 [1.03-1.11],0.0002690342223147
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17280,187,1.07 [0.91-1.26],0.392306723562565
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17666,573,1.10 [1.00-1.21],0.0406421036020188
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23672,280,1.06 [0.93-1.21],0.3589648737587747
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23484,92,0.98 [0.78-1.24],0.8681436712098655
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17248,155,1.13 [0.95-1.34],0.1788590286972762
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17158,65,1.04 [0.79-1.37],0.7812723169467513
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23553,739,1.05 [0.97-1.14],0.252894379682632
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17404,311,1.17 [1.03-1.32],0.0169209606334699
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17475,382,0.92 [0.82-1.03],0.1455327501961482
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17829,736,1.09 [1.00-1.18],0.0390407903962715
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17236,143,0.87 [0.72-1.05],0.1560836429491451
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23477,85,1.00 [0.78-1.27],0.984534391307454
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17662,569,1.12 [1.02-1.23],0.0142631413691163
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17486,393,1.07 [0.95-1.19],0.2504967070865678
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21433,69,1.08 [0.83-1.41],0.5617728545047453
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22292,5199,1.05 [1.02-1.08],0.0022340925105587
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22834,20,1.07 [0.65-1.74],0.793263384782197
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22835,21,1.02 [0.63-1.64],0.9360226639218014
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23559,1779,0.96 [0.91-1.02],0.1856047193708196
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23556,1775,0.97 [0.92-1.02],0.2017378455619552
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22836,22,1.72 [1.12-2.65],0.0137041225573723
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23457,789,1.04 [0.96-1.12],0.3338789910533143
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18718,1625,1.05 [0.99-1.11],0.103644520146846
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23719,266,0.99 [0.87-1.14],0.9284168461802068
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22722,109,0.98 [0.79-1.22],0.8757826842082174
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22743,75,1.04 [0.81-1.34],0.751350110970486
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22752,84,1.28 [1.02-1.62],0.035316341675641
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17156,63,1.15 [0.88-1.52],0.3117948976766216
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20942,159,1.00 [0.84-1.20],0.9656595614051704
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2498,123,1.01 [0.82-1.23],0.9390007721231922
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2658,316,0.92 [0.81-1.04],0.1920037173278955
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20881,98,1.06 [0.85-1.31],0.6270231581672976
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2453,80,0.94 [0.73-1.21],0.6353652130781915
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22943,2160,1.05 [1.00-1.10],0.0361556015413549
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22967,354,0.88 [0.78-1.00],0.0483983070915896
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21604,240,1.03 [0.89-1.19],0.6711816987507385
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17897,804,1.08 [1.00-1.17],0.0560681752872793
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23606,253,0.96 [0.84-1.11],0.5971079523454017
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22499,272,0.89 [0.78-1.02],0.0895518548342176
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,20815,1493,0.97 [0.92-1.03],0.3702474688683267
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22608,381,0.94 [0.83-1.05],0.2508848431655328
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22312,85,1.21 [0.96-1.53],0.1086269017981216
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22473,246,1.15 [1.00-1.32],0.0461774946297572
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,13884,2316,0.96 [0.92-1.01],0.1243224908660105
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,AV-block,19063,621,1.01 [0.92-1.10],0.8978743227877263
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23656,535,0.94 [0.85-1.03],0.1749312520442191
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,11819,251,1.10 [0.96-1.27],0.1600525616207898
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18647,205,0.88 [0.75-1.03],0.112241192521656
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18555,113,0.89 [0.72-1.10],0.2912251569468443
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23731,69,1.04 [0.79-1.36],0.7899515563924269
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,19812,1370,1.00 [0.94-1.06],0.9825973599997814
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,21920,2621,1.02 [0.98-1.07],0.2764306175873924
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19966,7737,1.03 [1.00-1.05],0.0337385369440643
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22505,277,0.94 [0.82-1.08],0.3786987114155363
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Endocarditis,18528,86,1.01 [0.79-1.28],0.9325624345561352
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23421,1328,1.04 [0.98-1.11],0.206423008027483
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,21168,6742,1.04 [1.02-1.07],0.0017958081185447
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21191,6765,1.04 [1.02-1.07],0.0019111286063845
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23504,113,0.89 [0.72-1.10],0.2842153211859911
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14610,184,1.01 [0.86-1.19],0.8992056893052529
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14595,169,1.14 [0.96-1.35],0.1247211924318761
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,23583,1228,1.09 [1.02-1.16],0.0102220623026167
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22661,119,0.83 [0.68-1.03],0.08619142775443
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22058,2736,1.01 [0.97-1.05],0.6403022860301841
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23297,652,1.08 [0.99-1.18],0.0708317139333907
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,18867,425,1.03 [0.93-1.15],0.558267990856139
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22997,1058,1.03 [0.96-1.10],0.4129622384828575
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20239,917,1.05 [0.97-1.12],0.2226327429445057
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23569,221,1.08 [0.93-1.25],0.3093559671666436
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23678,370,0.98 [0.87-1.10],0.7317494297435874
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,22299,71,0.81 [0.62-1.06],0.1285772584607264
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other aneurysm,22324,97,1.06 [0.85-1.33],0.5990762602231678
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,18926,484,1.03 [0.93-1.14],0.5172724470262049
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22363,136,1.13 [0.94-1.36],0.2085338104399396
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22511,284,0.96 [0.84-1.10],0.5714205745803236
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18638,196,1.02 [0.87-1.20],0.7907325939544341
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,22325,97,0.99 [0.79-1.24],0.9365351749261634
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22279,51,1.17 [0.86-1.58],0.3100474269240235
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22139,91,1.04 [0.82-1.31],0.748822322392586
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22336,108,0.95 [0.77-1.19],0.675379187790007
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19690,1248,0.97 [0.91-1.04],0.4162667450604227
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22422,67,0.96 [0.73-1.26],0.7445648727625596
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22799,572,1.12 [1.02-1.23],0.0128857274515321
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23084,362,1.06 [0.95-1.20],0.2983908595459479
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22722,674,1.01 [0.93-1.10],0.8281590932042375
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11950,382,0.90 [0.80-1.01],0.0779279397996773
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22706,527,1.09 [0.99-1.20],0.0743804236250671
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22584,356,0.93 [0.83-1.05],0.2236782842008393
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23221,499,0.99 [0.90-1.09],0.829986239855552
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23668,722,0.99 [0.91-1.08],0.8548532991756355
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,18916,474,0.98 [0.88-1.09],0.687255228014934
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23082,360,1.06 [0.94-1.19],0.3103849485951894
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22270,222,1.09 [0.94-1.26],0.2477246715374546
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23284,742,1.05 [0.97-1.14],0.230714127946877
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23268,772,1.05 [0.97-1.13],0.2654526824484083
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22635,48,0.85 [0.62-1.18],0.3352383459040576
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22340,114,0.84 [0.68-1.04],0.1136593505385868
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22897,252,1.04 [0.91-1.20],0.5648818448807413
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22253,314,1.05 [0.93-1.19],0.4556041188200661
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,22606,378,0.97 [0.87-1.09],0.6152836829289869
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22245,76,0.88 [0.68-1.14],0.3353357558069965
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23493,785,0.95 [0.88-1.03],0.2303348382013963
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23534,498,1.06 [0.96-1.17],0.2479347894863693
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20389,960,1.07 [1.00-1.15],0.0483804325561658
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,23046,3617,1.03 [0.99-1.07],0.1057229638776174
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23476,589,1.05 [0.96-1.15],0.2426498252761154
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20604,1175,1.08 [1.02-1.16],0.0120766587086841
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19514,85,1.03 [0.81-1.31],0.8007268473643467
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,23084,1520,1.02 [0.96-1.08],0.5433876260338705
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21289,1860,1.02 [0.97-1.08],0.3660928436608173
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Vascular dementia,23223,150,0.84 [0.70-1.02],0.0796698220192102
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Alzheimer disease,23729,298,0.96 [0.84-1.09],0.4984831049476548
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",15758,58,0.95 [0.70-1.29],0.746189641468236
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Bell's palsy,22365,78,1.06 [0.83-1.36],0.6413870779147605
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22619,332,1.05 [0.93-1.19],0.3869096811956195
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral cysts,23331,237,1.03 [0.89-1.19],0.7046567093314431
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23644,364,0.99 [0.88-1.11],0.8076161711643614
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23219,58,1.12 [0.84-1.49],0.4435210893182745
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23710,75,0.84 [0.65-1.09],0.1942147040646168
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23187,93,1.04 [0.83-1.31],0.7324192532232929
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,22109,286,0.95 [0.83-1.08],0.4535290207937524
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23191,1368,1.03 [0.97-1.09],0.3502927218903885
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23694,678,0.96 [0.88-1.05],0.4033587410854276
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23187,2196,0.99 [0.94-1.04],0.6718047896004049
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,23342,60,1.07 [0.81-1.41],0.6580641419580744
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,23561,281,1.01 [0.89-1.16],0.8301524067591469
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hydrocephalus,23150,56,1.10 [0.83-1.47],0.5054094092655832
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23713,61,1.35 [1.03-1.76],0.0270475777758812
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22307,20,0.64 [0.38-1.09],0.098354064569157
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22379,92,1.06 [0.85-1.34],0.5963776299306602
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Memory loss,23061,119,0.83 [0.68-1.03],0.0890712308645123
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,22020,197,1.04 [0.89-1.21],0.6555142632951271
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23706,177,1.07 [0.91-1.26],0.426236677337179
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Motor neuron disease,15860,147,1.13 [0.95-1.35],0.1758861458288433
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23620,64,0.97 [0.74-1.27],0.8210669210599764
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23260,973,1.06 [0.98-1.13],0.1241383387717002
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,22418,3666,1.02 [0.98-1.06],0.3341072425467661
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23403,242,0.99 [0.86-1.15],0.945062160896927
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22681,394,1.09 [0.98-1.22],0.1289183490664155
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23634,356,1.03 [0.92-1.16],0.5699219733141196
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18603,623,1.01 [0.93-1.11],0.7601629806060555
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23171,77,0.92 [0.71-1.19],0.5189991263547806
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23245,151,0.89 [0.74-1.07],0.2317930473598676
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23154,138,0.95 [0.79-1.15],0.6082308843566091
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22384,97,1.02 [0.82-1.28],0.8431824976020845
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other headache syndromes,21862,39,0.88 [0.62-1.27],0.4978384540361186
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23613,519,1.01 [0.91-1.11],0.8899738811014346
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22526,703,1.06 [0.97-1.15],0.188597614900739
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Parkinson's disease,23708,531,0.97 [0.88-1.07],0.5436921677850197
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23121,27,0.99 [0.65-1.51],0.9772775420887534
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,23730,49,1.13 [0.83-1.54],0.4483216340466978
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23424,633,1.05 [0.96-1.15],0.2587058024388651
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23336,58,1.02 [0.76-1.36],0.8895902792840428
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23713,172,1.15 [0.97-1.35],0.0978258160446717
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22320,33,0.92 [0.62-1.36],0.6844195717800552
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23729,301,0.96 [0.84-1.09],0.5119372603096675
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23192,146,0.84 [0.70-1.02],0.0824508755623006
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23183,86,1.17 [0.93-1.48],0.1863757400130983
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23384,299,0.92 [0.81-1.05],0.2195206762317121
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23528,289,0.91 [0.79-1.04],0.1494378298310355
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22858,42,0.91 [0.64-1.30],0.6125114392768665
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22878,62,1.17 [0.90-1.54],0.2417417667953806
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23638,46,1.18 [0.85-1.62],0.3220427333635078
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23501,121,1.02 [0.84-1.25],0.8115099018322919
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2457,82,0.95 [0.74-1.22],0.6937709051181151
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2994,130,1.06 [0.87-1.29],0.5475107997996083
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23190,93,1.38 [1.11-1.72],0.0034715347576897
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23479,988,0.97 [0.90-1.04],0.4026861146258943
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23429,613,0.98 [0.90-1.08],0.7296352400118191
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22960,144,1.14 [0.95-1.36],0.175072239204859
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23654,569,0.98 [0.89-1.07],0.6573493218863311
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23727,66,1.11 [0.85-1.45],0.4498997132911915
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23584,499,0.95 [0.86-1.05],0.3185472878132854
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23691,311,1.01 [0.89-1.15],0.8634134672348731
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23640,150,1.20 [1.01-1.43],0.0399774850685306
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22893,77,1.05 [0.81-1.35],0.7182876611536884
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22902,86,0.91 [0.71-1.16],0.4519778091599257
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22859,43,1.10 [0.78-1.54],0.5872090198829709
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23634,675,1.04 [0.95-1.13],0.4201302798657985
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23140,181,1.05 [0.89-1.24],0.5680122609088618
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23113,28,0.61 [0.39-0.95],0.0291890801702226
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23473,93,0.97 [0.77-1.22],0.7859782573872081
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23603,223,0.99 [0.86-1.15],0.9381012857111724
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23255,170,1.04 [0.88-1.23],0.6725148494047206
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23574,84,1.16 [0.92-1.47],0.2069996803904412
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23415,456,1.09 [0.98-1.20],0.1179360198917693
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23227,130,1.06 [0.88-1.29],0.5422977287328749
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22367,1786,1.05 [0.99-1.10],0.0983944957032674
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23574,194,0.97 [0.83-1.14],0.7343252202148283
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23715,147,1.04 [0.87-1.25],0.6424629476484214
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23232,416,0.94 [0.84-1.05],0.2796120492457203
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23443,63,0.93 [0.70-1.23],0.6016451088518324
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23716,55,1.11 [0.83-1.49],0.4863183178582094
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22892,76,0.82 [0.63-1.07],0.1431836344631816
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22956,140,0.87 [0.72-1.06],0.158310422748108
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22619,128,1.00 [0.82-1.22],0.9963901503298483
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23137,52,1.05 [0.78-1.42],0.7456550782234668
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22554,63,0.91 [0.69-1.21],0.5228038958020531
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23009,50,0.94 [0.69-1.29],0.7070659210625827
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23167,208,1.08 [0.93-1.26],0.3268130575778117
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22933,117,1.02 [0.83-1.25],0.8743945693490124
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22613,122,1.25 [1.03-1.52],0.021030627553487
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22586,95,0.87 [0.69-1.10],0.2382236669851066
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22045,1464,1.01 [0.95-1.07],0.7054843035524663
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22874,58,1.00 [0.74-1.34],0.9898840399347392
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23486,389,1.18 [1.05-1.31],0.0036982717021861
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23166,69,1.13 [0.87-1.47],0.3472403522150042
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23267,170,1.05 [0.89-1.24],0.5583818306067326
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23556,58,0.95 [0.71-1.27],0.7117973572525524
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23687,120,1.03 [0.84-1.26],0.7860923747323996
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23595,112,1.15 [0.94-1.41],0.1837842746971511
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23548,50,1.02 [0.75-1.39],0.9063355989477856
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23552,54,1.08 [0.80-1.45],0.6157639253616851
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23636,972,1.04 [0.97-1.12],0.2773192723500787
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23384,720,1.05 [0.97-1.14],0.2622750780545351
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22793,129,0.82 [0.67-1.00],0.0465241257931036
PPP1R2,Protein phosphatase inhibitor 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22750,86,1.23 [0.97-1.54],0.0826957210226264
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,23517,63,0.98 [0.74-1.29],0.8785201320110829
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23645,191,0.95 [0.81-1.12],0.5377316273549957
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23517,63,0.86 [0.65-1.15],0.314634211550626
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza,21448,108,1.14 [0.92-1.40],0.227467721945248
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21445,105,1.17 [0.95-1.45],0.137623501558819
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15548,104,1.04 [0.84-1.29],0.6935761207747636
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,23623,267,1.04 [0.91-1.19],0.5626129903363657
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16531,1430,1.06 [1.00-1.12],0.0410806210228874
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16848,1404,1.06 [1.00-1.13],0.0411331628955501
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23346,152,1.18 [0.99-1.41],0.0662557937787608
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21436,96,1.16 [0.93-1.45],0.1856845388927422
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Bronchiectasis,20621,291,1.13 [0.99-1.28],0.0694903463846911
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20376,46,1.70 [1.26-2.29],0.00045518860876
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22877,2547,1.06 [1.02-1.11],0.0066229666746263
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22290,79,1.16 [0.91-1.48],0.2218097418921816
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22371,160,1.10 [0.93-1.31],0.2541788949337486
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23510,1296,1.04 [0.98-1.11],0.1915177960414291
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22348,137,1.00 [0.83-1.21],0.9879340492517492
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21724,5262,1.04 [1.01-1.07],0.0175951944466786
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22602,391,1.03 [0.93-1.16],0.542084021179772
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,22516,302,1.00 [0.88-1.13],0.9501149382625982
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Emphysema,20680,350,1.10 [0.98-1.23],0.1207064506175409
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22809,341,1.08 [0.96-1.22],0.1831587222913371
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23488,2148,1.05 [1.01-1.11],0.0301532129471907
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22838,370,1.11 [0.99-1.25],0.0673055861685197
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Later onset COPD,22671,994,1.06 [0.98-1.13],0.1281058201672178
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23713,428,1.08 [0.97-1.20],0.1729115837987104
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,22354,143,1.08 [0.90-1.30],0.3865667141513819
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23461,1001,1.11 [1.03-1.19],0.0037292808855882
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,23449,2192,1.07 [1.02-1.12],0.0049165693806332
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23079,868,1.03 [0.96-1.11],0.4554853892387225
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other pleural conditions,21324,67,1.07 [0.82-1.39],0.6350744743380008
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23636,452,1.11 [1.00-1.23],0.0453053516768259
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23610,1388,1.10 [1.03-1.16],0.0019058166478125
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,22379,1122,1.07 [1.00-1.14],0.0463442869519338
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural plaque,21520,263,1.00 [0.87-1.15],0.9692551049526036
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23225,1885,1.06 [1.00-1.11],0.0361588051929028
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23613,328,1.09 [0.96-1.23],0.1861223720896052
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pneumothorax,21399,142,0.91 [0.75-1.09],0.3072194471226921
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pollen allergy,23715,233,1.08 [0.94-1.25],0.2685913307038023
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,23252,68,1.04 [0.79-1.36],0.7841971761669049
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15499,55,1.15 [0.86-1.55],0.3456006213968704
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23444,984,1.11 [1.03-1.19],0.0036839323472751
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22480,269,1.05 [0.92-1.19],0.4957755450999949
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Viral pneumonia,21620,280,1.01 [0.89-1.16],0.8496516048311283
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23361,238,0.96 [0.83-1.11],0.5919728583351032
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10326,119,0.97 [0.79-1.20],0.8060003838182259
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16572,89,1.09 [0.87-1.38],0.4572601453603747
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23599,141,1.15 [0.96-1.38],0.1181022092201026
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute gastritis,17904,89,1.01 [0.80-1.27],0.9496154671978012
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22372,203,0.96 [0.82-1.12],0.5831389249550042
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute peritonitis,23371,98,1.04 [0.83-1.30],0.7244729951563615
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22842,115,0.89 [0.72-1.09],0.2536608349257018
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,18341,526,0.96 [0.87-1.06],0.3870971847099261
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22292,123,0.94 [0.77-1.15],0.5634648830652449
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23327,123,0.94 [0.76-1.15],0.5278444091962518
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,22389,220,0.93 [0.80-1.08],0.3247709574865688
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22954,785,1.06 [0.98-1.14],0.175991264072154
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,18082,267,0.93 [0.81-1.07],0.3137937307195476
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22225,56,0.99 [0.74-1.33],0.9572395995925396
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23527,136,0.89 [0.73-1.08],0.2441471902460548
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,22107,95,1.18 [0.94-1.46],0.1513460172053539
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Collagenous colitis,22295,49,1.17 [0.86-1.60],0.3090066937796928
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23564,222,0.90 [0.78-1.05],0.1785190436229412
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,23564,1597,1.02 [0.97-1.08],0.4665586568238278
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,22336,90,1.10 [0.88-1.39],0.4029717372309394
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23388,65,1.08 [0.82-1.41],0.5901357330639025
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22322,76,1.20 [0.93-1.53],0.1545134519927529
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,23082,222,1.12 [0.97-1.30],0.1195860728156508
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20087,1938,1.00 [0.95-1.05],0.8928859822731325
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23629,171,1.07 [0.90-1.26],0.4390605379886357
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,23592,865,0.97 [0.90-1.05],0.5069452507094417
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21733,3918,1.02 [0.98-1.06],0.2700220381835108
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23370,510,1.07 [0.97-1.18],0.1509472803665354
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23681,408,1.05 [0.94-1.17],0.4026007549381337
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22969,109,1.14 [0.93-1.40],0.2224863574905837
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22828,67,1.07 [0.82-1.39],0.6410847049485502
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23410,1398,1.03 [0.97-1.10],0.2659675441379355
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of tongue,22848,107,1.01 [0.82-1.25],0.9402907437447922
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23361,1192,1.02 [0.96-1.09],0.5231252836477065
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19520,3037,0.99 [0.95-1.03],0.6926531252177448
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,18079,264,1.00 [0.87-1.14],0.9787183715569396
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23615,209,1.00 [0.86-1.17],0.9559110383175956
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23655,46,1.20 [0.88-1.64],0.2505497386984533
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22886,159,0.91 [0.76-1.09],0.2887891798914762
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16663,180,0.88 [0.74-1.04],0.1289500618995049
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,18235,420,1.00 [0.90-1.12],0.9603337107111256
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,18183,368,1.12 [1.00-1.25],0.0562727500373203
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19967,2152,1.03 [0.98-1.08],0.2421587656899492
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18411,596,1.06 [0.97-1.16],0.2056832266717971
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18131,7946,1.00 [0.98-1.03],0.954169293046034
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,23173,1161,1.01 [0.95-1.08],0.7361595157382805
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22903,43,1.29 [0.94-1.78],0.1166214582455041
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17441,1226,0.96 [0.90-1.02],0.230317032918906
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22811,84,0.95 [0.75-1.22],0.7104299126689966
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,21680,3531,1.00 [0.96-1.03],0.85985799693947
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,23658,43,1.32 [0.96-1.81],0.0925018362280769
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impaction of intestines,16530,47,0.79 [0.56-1.10],0.166570171030314
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,19780,1631,1.00 [0.95-1.06],0.8621336865250295
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18345,196,0.96 [0.82-1.13],0.6288170902807002
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16571,88,1.00 [0.79-1.27],0.995228091616144
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22120,108,1.19 [0.97-1.47],0.0905312525129925
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16755,272,0.93 [0.81-1.06],0.2842391330192148
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23688,375,1.02 [0.91-1.15],0.697344571391095
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22927,681,1.08 [0.99-1.17],0.0884006129822022
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23134,888,1.06 [0.98-1.14],0.1322147235897934
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18028,213,0.95 [0.82-1.11],0.5398392884790753
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,18443,628,1.05 [0.97-1.15],0.2404978145940161
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23678,115,1.11 [0.90-1.35],0.3274586023643163
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18228,79,1.09 [0.85-1.40],0.4782551840128739
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17901,1418,1.00 [0.94-1.06],0.9203236464662315
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22429,260,0.99 [0.86-1.14],0.8847877365713015
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22292,123,1.05 [0.87-1.28],0.5978134648853544
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18354,1871,0.99 [0.94-1.04],0.6116942111736362
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,21922,5439,0.99 [0.96-1.02],0.5183268541723862
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22812,182,1.12 [0.96-1.31],0.161458132840802
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23420,693,0.94 [0.87-1.03],0.178000044458588
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18547,732,0.98 [0.90-1.07],0.6562754539637035
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22310,141,0.92 [0.76-1.11],0.372612844478335
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23609,336,1.06 [0.94-1.19],0.3632750575137138
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18620,805,1.00 [0.92-1.08],0.9039750737630536
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23185,1173,1.01 [0.95-1.08],0.7210185234489137
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23038,178,1.13 [0.96-1.33],0.1324851024185472
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18117,1634,1.01 [0.95-1.06],0.7780139464307363
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19676,1861,1.00 [0.95-1.05],0.9967239816640876
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22823,96,0.83 [0.66-1.05],0.1164993572746233
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23024,778,1.05 [0.97-1.13],0.2339818606587464
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16834,351,0.94 [0.83-1.06],0.3122268860180446
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23646,56,1.19 [0.90-1.58],0.2277956628986947
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16958,475,0.95 [0.86-1.06],0.349543907768254
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22174,162,1.12 [0.95-1.33],0.1864057854358045
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23717,43,0.90 [0.64-1.27],0.56084975688086
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22869,106,1.13 [0.92-1.39],0.2461654167989805
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Toxic colitis,22292,46,0.74 [0.53-1.05],0.0877127946774656
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18114,299,1.05 [0.93-1.20],0.4121269731764851
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22396,150,1.11 [0.93-1.32],0.2661230409279992
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22371,125,0.99 [0.81-1.21],0.9259317657718024
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,18521,372,0.98 [0.88-1.10],0.7611166394243333
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16643,160,0.93 [0.78-1.11],0.432787641393248
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,18413,264,1.01 [0.88-1.16],0.8961896660407119
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Volvulus,16555,72,0.92 [0.70-1.20],0.5258907767929881
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23654,322,0.96 [0.84-1.08],0.4754958325594015
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23417,68,1.26 [0.97-1.63],0.0823906948445869
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21739,96,0.93 [0.74-1.17],0.5596420338901731
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22994,751,1.00 [0.93-1.09],0.9279449732280208
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22443,200,1.02 [0.87-1.19],0.8349951628975036
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22112,469,1.02 [0.92-1.13],0.6703403949403328
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23438,271,1.13 [0.99-1.29],0.0616044447019744
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23639,472,1.12 [1.02-1.24],0.0222911015077811
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23210,43,1.26 [0.91-1.75],0.1551021553887426
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22241,3163,1.00 [0.96-1.04],0.9961928862932568
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23282,409,0.98 [0.88-1.09],0.7063944488871188
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23169,296,0.97 [0.85-1.10],0.6296238931941798
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23270,1027,0.99 [0.93-1.07],0.8777497777932491
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23721,31,1.21 [0.82-1.77],0.3446615921556279
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21665,22,1.49 [0.96-2.31],0.0749529567119375
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22931,58,1.01 [0.75-1.35],0.9719204279778172
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23434,267,1.12 [0.98-1.28],0.0903222453607649
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22124,481,0.97 [0.87-1.07],0.4931115323936215
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21723,80,0.93 [0.72-1.19],0.5654665113243452
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23663,81,1.07 [0.84-1.37],0.5878882812914392
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22464,221,1.12 [0.97-1.30],0.1281763536772233
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23562,213,1.10 [0.95-1.28],0.2143294830695755
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23236,69,1.01 [0.77-1.32],0.9341896280025626
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21709,66,0.83 [0.63-1.10],0.1999512096018991
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23272,1629,1.00 [0.94-1.05],0.867084315241853
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22164,521,0.97 [0.88-1.07],0.4960254272191767
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21726,83,0.93 [0.73-1.19],0.5794339271910676
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23641,292,1.14 [1.00-1.29],0.0462456944100197
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23222,55,1.22 [0.91-1.63],0.1784634933917435
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23604,255,1.14 [1.00-1.31],0.0565563939642054
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23674,342,0.94 [0.83-1.06],0.3357273328664041
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21732,89,0.96 [0.75-1.21],0.7029729990971931
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21911,268,0.87 [0.76-1.00],0.043934241491637
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23667,335,0.94 [0.84-1.07],0.3534660169611068
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21909,266,1.06 [0.93-1.22],0.3696872102673354
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23705,123,1.09 [0.89-1.32],0.4037276053955853
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20484,92,1.00 [0.79-1.26],0.9866015354350932
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21650,4765,1.04 [1.01-1.07],0.0128996441671052
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20239,3354,1.03 [1.00-1.07],0.0851492686869115
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20463,71,0.90 [0.69-1.17],0.4220290524983341
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20828,148,1.03 [0.86-1.23],0.7521420271455925
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20826,146,1.17 [0.98-1.40],0.0900376596268235
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23530,69,1.01 [0.78-1.31],0.950687770220288
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20761,81,0.99 [0.78-1.27],0.9671524837607752
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17743,858,1.05 [0.97-1.13],0.2026971421423452
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23612,150,1.04 [0.87-1.24],0.6927079524177433
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20951,271,1.04 [0.91-1.19],0.5686838882547773
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20187,6250,1.04 [1.01-1.07],0.0050887769624752
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22675,93,0.78 [0.61-0.98],0.0345680237150741
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20558,166,0.83 [0.70-0.99],0.0400553189871606
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20829,437,1.02 [0.92-1.14],0.6745661043961542
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22908,2228,1.02 [0.97-1.07],0.4364317505217652
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20758,366,0.95 [0.85-1.07],0.3910440829918093
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20444,52,1.41 [1.06-1.87],0.0188113111491262
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20488,96,1.05 [0.84-1.31],0.6536491954616521
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23414,31,1.45 [1.00-2.12],0.0500285820311203
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18346,1461,1.04 [0.98-1.10],0.2009763846953382
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17860,975,1.11 [1.03-1.19],0.0038111626443857
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23589,961,1.11 [1.03-1.19],0.0046791635711239
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16932,47,0.86 [0.62-1.19],0.3705329227867685
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16963,78,1.09 [0.85-1.39],0.5090071884477041
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20660,268,1.00 [0.88-1.15],0.9799554630686234
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17513,628,1.04 [0.95-1.13],0.3974447953715657
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20722,42,1.29 [0.93-1.79],0.1316313475316738
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21210,530,1.03 [0.94-1.14],0.4836422138786235
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20947,267,1.05 [0.92-1.20],0.4977046335194857
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17471,586,1.01 [0.92-1.10],0.9001681545996663
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20456,64,1.08 [0.83-1.42],0.5586548432327332
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20446,54,0.97 [0.72-1.31],0.848318357232214
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22675,93,1.00 [0.79-1.25],0.9769331158527462
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23445,863,0.97 [0.90-1.04],0.3887393721368588
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22984,402,0.95 [0.85-1.06],0.3230124663088574
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23651,286,1.11 [0.98-1.27],0.0979865212804612
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18760,1875,1.05 [1.00-1.11],0.0562135266990077
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16937,52,0.84 [0.62-1.15],0.2735561016040066
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20476,84,1.23 [0.98-1.55],0.0805500065393707
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16940,55,0.97 [0.72-1.31],0.8357643642852111
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16931,46,0.91 [0.65-1.25],0.5501057553814834
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22766,184,1.00 [0.85-1.18],0.9840108429921708
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22745,163,1.00 [0.84-1.18],0.9629669543086634
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23694,84,1.08 [0.85-1.37],0.5346601206213744
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22203,1523,1.04 [0.98-1.10],0.1617438752102235
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20458,66,1.07 [0.82-1.39],0.6296304695562889
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16924,39,1.24 [0.88-1.75],0.2199124496340801
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21303,623,1.07 [0.98-1.17],0.1146186025061637
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18591,1706,1.04 [0.98-1.09],0.191442331958068
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23439,56,1.42 [1.07-1.87],0.0150980299795334
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23713,62,1.29 [0.98-1.68],0.0666393341402223
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20472,80,1.03 [0.81-1.32],0.8037507848939318
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21376,984,1.07 [1.00-1.15],0.0432728876464801
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20485,93,0.90 [0.72-1.14],0.3919987566420677
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18092,1207,1.03 [0.96-1.09],0.4082541878037704
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22665,83,0.96 [0.75-1.22],0.7190931451684563
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20437,45,1.30 [0.95-1.78],0.1016237239521027
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20789,109,0.92 [0.74-1.14],0.4452198674066716
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20899,507,1.01 [0.92-1.12],0.8070709116410162
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23577,194,1.05 [0.90-1.23],0.532409545459973
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21158,478,1.07 [0.97-1.18],0.2013028549321263
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23659,279,1.10 [0.97-1.26],0.1422675847588113
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23715,38,1.12 [0.79-1.60],0.5246618947941795
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20542,150,0.91 [0.75-1.09],0.282711271546204
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19447,570,1.08 [0.98-1.18],0.1038528682530834
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20871,479,1.07 [0.97-1.19],0.1563180120180116
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20722,330,0.92 [0.81-1.04],0.1839648504281816
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16914,29,1.09 [0.73-1.64],0.6741526031702807
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19148,2263,1.07 [1.02-1.12],0.0047821804394915
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17340,455,0.97 [0.87-1.07],0.5301165195711407
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23546,163,1.02 [0.86-1.22],0.8185461816873253
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23656,46,0.98 [0.70-1.36],0.8842163756269927
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21748,46,1.08 [0.77-1.50],0.6650005262394529
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16949,64,1.27 [0.97-1.65],0.0831349329723082
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20764,84,1.07 [0.84-1.36],0.5715762362032344
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17178,293,1.11 [0.97-1.26],0.1172344562750346
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20663,271,1.08 [0.94-1.23],0.2800738829184447
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20894,214,1.19 [1.03-1.38],0.0182176821288053
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20774,94,1.09 [0.87-1.37],0.4570897691323978
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18835,30,1.35 [0.91-1.99],0.1323323574012808
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23716,39,1.13 [0.80-1.61],0.4770816244784861
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20916,524,1.02 [0.93-1.13],0.6163224456072074
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23404,21,1.04 [0.64-1.69],0.8723576095830416
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22662,2270,1.03 [0.98-1.08],0.1882357813776523
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20499,107,1.22 [0.99-1.50],0.0573570786893208
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21191,511,1.03 [0.93-1.14],0.545209386569611
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22676,194,0.95 [0.81-1.12],0.5607644119130901
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20808,128,0.92 [0.76-1.13],0.4315954374920377
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21995,1315,1.02 [0.96-1.09],0.4301581357853492
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21499,819,1.03 [0.96-1.12],0.4108678219888103
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20436,44,1.26 [0.92-1.74],0.1538736970014186
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23423,40,1.50 [1.09-2.08],0.0133329462756697
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20510,118,1.15 [0.94-1.41],0.1640169264422128
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20415,23,0.97 [0.60-1.55],0.8918482217845208
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16945,60,0.86 [0.65-1.15],0.3196122595322078
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22723,1859,1.05 [0.99-1.10],0.0844742125447064
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23256,406,1.02 [0.91-1.13],0.7822771629342903
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22988,138,0.90 [0.74-1.09],0.2765061132264038
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22410,1546,1.03 [0.97-1.09],0.3746606308363285
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23480,85,1.06 [0.83-1.36],0.6177355011804362
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23447,353,1.00 [0.89-1.13],0.9880839147134106
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,20880,213,1.10 [0.94-1.27],0.2353756021583833
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dialysis,20969,105,1.23 [0.99-1.51],0.0586632933856746
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22456,3298,1.01 [0.97-1.05],0.6421632558442603
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21364,5551,1.00 [0.97-1.03],0.865532768834167
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23496,101,1.07 [0.86-1.33],0.5595512925379486
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19364,206,0.89 [0.76-1.04],0.1577570335385954
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,20966,367,1.11 [0.99-1.25],0.0654708148132029
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21744,2586,1.01 [0.97-1.06],0.6181429864831722
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19393,235,0.96 [0.83-1.12],0.6236382796942244
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20747,80,0.87 [0.68-1.12],0.2851880976981585
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19266,108,0.88 [0.71-1.09],0.2503034443726502
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23719,62,1.00 [0.75-1.32],0.9900331998089894
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23723,57,0.81 [0.60-1.09],0.1644293310118195
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22894,2227,1.00 [0.95-1.05],0.9833306418399144
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21614,947,0.97 [0.90-1.05],0.457048977736014
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23654,560,1.00 [0.91-1.10],0.9790262172912744
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19465,307,0.97 [0.86-1.10],0.6511421822629251
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19443,285,1.04 [0.92-1.19],0.5249056350222701
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19390,232,0.93 [0.80-1.08],0.3245067680451021
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23714,48,1.05 [0.77-1.45],0.7435116718298143
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22181,1514,1.02 [0.97-1.08],0.4478304891330511
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21008,409,1.09 [0.98-1.21],0.1265523321459819
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23283,189,0.97 [0.82-1.14],0.6987559036151031
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23453,58,0.98 [0.73-1.31],0.8855084240639006
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19421,263,1.04 [0.91-1.19],0.5513467426970986
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23426,2827,1.04 [1.00-1.08],0.0780074712045376
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20670,71,1.08 [0.83-1.39],0.5845021178225123
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21023,159,0.90 [0.75-1.08],0.2612565276698029
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22924,74,1.08 [0.84-1.39],0.5448896567982995
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20961,294,0.96 [0.84-1.09],0.4938552588744974
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23371,521,0.98 [0.89-1.08],0.6714022331429386
